MOH
- Marketing authorisation holder: NOVARTIS
- Status: likely_approved
🇮🇱 Vanrafia in Israel
Vanrafia (ATRASENTAN) regulatory status in Israel.
Marketing authorisation
Vanrafia in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Israel
Frequently asked questions
Is Vanrafia approved in Israel?
Yes. MOH has authorised it.
Who is the marketing authorisation holder for Vanrafia in Israel?
NOVARTIS holds the Israeli marketing authorisation.